Skip Navigation

Sharing Knowledge.

Supporting People.

Advancing Care.

About the Bronchiectasis and NTM Association

The Bronchiectasis and NTM Association is dedicated to improving the lives of people affected by bronchiectasis and NTM lung disease. The Association is committed to advancing high-quality, specialized care, research, education, support, and advocacy within the bronchiectasis and NTM lung disease communities, helping people live longer, healthier lives.

Latest Activity

Read the latest activity from our blog, press releases and BronchandNTM360social, our online community.

Latest Blog Post

Blog

What Is the Bronchiectasis and NTM Care Center Network?

This blog post was authored by Lucinda Shore and reviewed by the Bronchiectasis and NTM Content Review and Evaluation Committee.As bronchiectasis and nontuberculous mycobacterial (NTM) lung disease become more common in the U.S., getting a quick, accurate diagnosis and expert care is very important. To help meet this need, the Bronchiectasis and NTM Association created the Bronchiectasis and NTM Care Center Network (CCN).The CCN connects people to medical centers throughout the U.S. that provide expert care and treatment, high-quality education, advice, and support for those living with bronchiectasis and NTM lung disease. The CCN gives sites one of two designations:Care Center: These centers offer a clinical research program, treat hundreds of people with bronchiectasis and NTM, and provide direct access to specialists (like dietitians or psychologists) for immediate care.Clinical Associate Center (CAC): CACs provide high-quality, expert care, but may see fewer people with both conditions, may be less involved in research, and may not have access to specialists within the center.

Read More
Abstracts

Press Release

Bronchiectasis and NTM Association announces Externally-Led Patient-Focused Drug Development meeting for non-cystic fibrosis bronchiectasis

The Bronchiectasis and NTM Association today announced plans for an Externally-Led Patient-Focused Drug Development (EL-PFDD) meeting for non-cystic fibrosis bronchiectasis (NCFB). This meeting is modeled after the Food & Drug Administration’s (FDA) PFDD public meetings. Drug developers, FDA, and other stakeholders will be in attendance.NCFB is a chronic lung disease characterized by inflammation and chronic infection in which the airways become abnormally widened, thickened, and/or scarred. Once considered rare, NCFB is now recognized more widely as awareness, research, and advances in imaging have improved understanding of the disease. Although the first FDA-approved treatment for NCFB became available in 2025, significant challenges remain. Many people still face delays in diagnosis, limited access to specialized care, and difficulties managing the disease’s daily impact.The NCFB EL-PFDD meeting will:Enhance understanding of how living with NCFB impacts daily life experiences;Capture diverse perspectives of the NCFB community to help foster timely and effective therapy development; andInform regulatory decision-making with insights on current care and treatment benefit needs.

Read More
360Social

Discussion

When Should a BNTM Patient See a Neuro-Ophthalmologist?

👁️ When Should a BNTM Patient See a Neuro-Ophthalmologist?  Unfortunately, some medications used to treat NTM lung disease can affect your vision. For BNTM patients, protecting your eyesight is another important part of managing your treatment.What is a neuro-ophthalmologist? A neuro-ophthalmologist is a medical specialist who focuses on vision problems related to the optic nerves, brain, and the nervous system. They evaluate problems involving the connection between your eyes and brain.Why might a BNTM patient need one?  Certain antibiotics used in NTM treatment can cause vision-related side effects.Two medications deserve particular attention:🔹 Ethambutol: Can cause optic neuropathy (damage to the optic nerve).May affect color vision, particularly red and green.Can cause blurred or decreased vision.🔹 Linezolid: With prolonged use, can cause optic neuropathy.May cause blurred vision or changes in visual acuity.Requires attention to new visual symptoms.When should you see a neuro-ophthalmologist? Consider a referral if you experience:Blurred or declining vision.Difficulty distinguishing colors.Changes in your central vision.Dark spots or blind spots in your visual field.Unexplained visual disturbances.New visual symptoms while taking potentially toxic medications.🚨 Don’t wait for your next appointment! Report new vision changes promptly to your prescribing physician. Some medication-related eye complications can become permanent if not recognized early.What about baseline testing? If you are prescribed ethambutol, ask your medical team about:A baseline comprehensive eye examination.Visual acuity testing.Color vision testing.Visual field testing when indicated.Follow-up monitoring throughout treatment.A neuro-ophthalmologist may be appropriate when optic nerve involvement is suspected or when a more specialized evaluation is needed. Routine monitoring may also be performed by an ophthalmologist experienced in medication-related eye toxicity.❤️ Your BNTM healthcare team should look beyond your lungs! Protecting your vision is part of protecting your overall quality of life.Have you had an eye examination before starting ethambutol? Did your NTM treatment team discuss vision monitoring with you? Share your experience. Patient education and awareness make a difference!

Read More

New Bronchiectasis Diagnoses

Approximately 70,000 adults are newly diagnosed with bronchiectasis each year in the United States. An estimated 350,000 to 500,000 adults in the U.S. currently living with the condition.

8,600+

Bronchiectasis and NTM Research Registry

The Registry connects people with research to advance care. Participants help support clinical trials and accelerate the development of new treatments.

5,100+

BronchandNTM360social Membership

Join our growing online community to find support, ask questions and connect with others.

Monthly giving is an easy and impactful

Make an Impact

Help us move our mission forward and expand trusted education, strengthen advocacy, advance research, and improve care and resources for patients, families, caregivers, and providers.

World Bronchiectasis Day

World Bronchiectasis Day

Observed annually on July 1, World Bronchiectasis Day is a global campaign designed to raise awareness of bronchiectasis.

Stay In Touch

Sign up for our newsletter for information on upcoming events, virtual meetups, new research, treatment tips, and more, delivered straight to your inbox.